|
|
|
|
|
<br>Modafinil, a wakefulness-selling agent, has garnered significant attention lately for its potential cognitive-enhancing results. Initially developed to treat narcolepsy and different sleep disorders, its off-label use for enhancing cognitive perform and productivity has led to a burgeoning market. In Poland, the availability and purchase of modafinil current distinctive challenges and issues, including legal rules, accessibility, and the implications of its use. |